J A Del-Moral-Luque1, A Checa-García2, Á López-Hualda2, M C Villar-Del-Campo3, J Martínez-Martín2, F J Moreno-Coronas2, J Montejo-Sancho2, G Rodríguez-Caravaca4. 1. Servicio de Medicina Preventiva y Salud Pública, Hospital Universitario Fundación Alcorcón, Madrid, España; Departamento de Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid, España. 2. Servicio de Cirugía Ortopédica y Traumatología, Hospital Universitario Fundación Alcorcón, Madrid, España. 3. Centro de Salud Los Cármenes, Madrid, España; Departamento de Medicina, Universidad Complutense, Madrid, España. 4. Servicio de Medicina Preventiva y Salud Pública, Hospital Universitario Fundación Alcorcón, Madrid, España; Departamento de Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid, España. Electronic address: grodriguez@fhalcorcon.es.
Abstract
OBJECTIVE: Antibiotic prophylaxis is the most suitable tool for preventing surgical wound infection. This study evaluated adequacy of antibiotic prophylaxis in surgery for knee arthroplasty and its effect on surgical site infection. MATERIAL AND METHOD: Prospective cohort study. We assessed the degree of adequacy of antibiotic prophylaxis, the causes of non-adequacy, and the effect of non-adequacy on surgical site infection. Incidence of surgical site infection was studied after a maximum incubation period of a year. To assess the effect of prophylaxis non-adequacy on surgical site infection we used the relative risk adjusted with the aid of a logistic regression model. RESULTS: The study covered a total of 1749 patients. Antibiotic prophylaxis was indicated in all patients and administered in 99.8% of cases, with an overall protocol adequacy of 77.6%. The principal cause of non-compliance was the duration of prescription of the antibiotics (46.5%). Cumulative incidence of surgical site infection was 1.43%. No relationship was found between prophylaxis adequacy and surgical infection (RR=1.15; 95% CI: .31-2.99) (P>.05). DISCUSSION: Surveillance and infection control programs enable risk factors of infection and improvement measures to be assessed. Monitoring infection rates enables us to reduce their incidence. CONCLUSIONS: Adequacy of antibiotic prophylaxis was high but could be improved. We did not find a relationship between prophylaxis adequacy and surgical site infection rate.
OBJECTIVE: Antibiotic prophylaxis is the most suitable tool for preventing surgical wound infection. This study evaluated adequacy of antibiotic prophylaxis in surgery for knee arthroplasty and its effect on surgical site infection. MATERIAL AND METHOD: Prospective cohort study. We assessed the degree of adequacy of antibiotic prophylaxis, the causes of non-adequacy, and the effect of non-adequacy on surgical site infection. Incidence of surgical site infection was studied after a maximum incubation period of a year. To assess the effect of prophylaxis non-adequacy on surgical site infection we used the relative risk adjusted with the aid of a logistic regression model. RESULTS: The study covered a total of 1749 patients. Antibiotic prophylaxis was indicated in all patients and administered in 99.8% of cases, with an overall protocol adequacy of 77.6%. The principal cause of non-compliance was the duration of prescription of the antibiotics (46.5%). Cumulative incidence of surgical site infection was 1.43%. No relationship was found between prophylaxis adequacy and surgical infection (RR=1.15; 95% CI: .31-2.99) (P>.05). DISCUSSION: Surveillance and infection control programs enable risk factors of infection and improvement measures to be assessed. Monitoring infection rates enables us to reduce their incidence. CONCLUSIONS: Adequacy of antibiotic prophylaxis was high but could be improved. We did not find a relationship between prophylaxis adequacy and surgical site infection rate.
Authors: M Garrote-Garrote; J A Del-Moral-Luque; A Checa-García; J F Valverde-Cánovas; C Campelo-Gutiérrez; J Martínez-Martín; A Gil-de-Miguel; G Rodríguez-Caravaca Journal: Rev Esp Quimioter Date: 2018-03-14 Impact factor: 1.553
Authors: M Gil-Conesa; J A Del-Moral-Luque; N Climent-Martínez; A Delgado-Iribarren; R Riera-Pérez; C Martín-Caballero; C Campello-Gutiérrez; M Durán-Poveda; G Rodríguez-Caravaca; A Gil-de-Miguel; D Rodríguez-Villar Journal: Rev Esp Quimioter Date: 2020-03-31 Impact factor: 1.553